Why the government blinked on eye injections – and why we will all pay the $100 million price
By Dr Rachel David Two years ago, the federal government made what looked like a straightforward, evidence-based decision about how a common medical procedure should be delivered. The plan was simple: move most intravitreal eye injections – used to treat conditions such as macular degeneration – out of hospital settings and into clinicians’ rooms where they are routinely and safely performed in Australia and around the world. The proposal followed detailed advice from the Medicare Benefits Schedule Review Taskforce, which was established to ensure taxpayers are paying for appropriate, value-based healthcare. After extensive consultation with clinicians, consumer groups and professional…
Read More 
